A. Okada et al., MEMBRANE-TYPE MATRIX METALLOPROTEINASE (MT-MMP) GENE IS EXPRESSED IN STROMAL CELLS OF HUMAN COLON, BREAST, AND HEAD AND NECK CARCINOMAS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(7), 1995, pp. 2730-2734
From breast cancer cDNA libraries,we have cloned cDNAs that proved to
correspond to the membrane-type matrix metalloproteinase (MT-MMP) rece
ntly identified in human placenta and proposed to be an activator of p
ro-gelatinase A [Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa,
A., Yamamoto, E. & Seiki, M. (1994) Nature (London) 370, 61-65]. Using
one of these cDNAs as a probe, we have detected MT-MMP gene expressio
n in all 83 human carcinoma specimens examined by RNA in situ hybridiz
ation and have found MT-MMP transcripts in fibroblastic cells of tumor
stroma but not in cancer cells. Comparison with other MMP genes expre
ssed in fibroblastic cells of human carcinomas indicated that the expr
ession pattern of the MT-MMP gene was more closely related to that of
the gelatinase A gene than to those of the stromelysin 3 or interstiti
al collagenase genes. These observations are consistent with the hypot
hesis that MT-MMP and gelatinase A are cooperating during tumor progre
ssion and strengthen the concept that proteolytic activities originati
ng from the stromal component of human carcinomas have a critical role
in tumor progression.